PANCREATIC NEUROENDOCRINE TUMORS (PNET)
Clinical trials for PANCREATIC NEUROENDOCRINE TUMORS (PNET) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE TUMORS (PNET) trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMORS (PNET), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can chemo stop pancreatic tumor return? major trial launches
Disease control Not yet recruitingThis phase 3 trial tests whether adding chemotherapy after surgery can prevent aggressive pancreatic neuroendocrine tumors from coming back. About 300 people who had their tumor fully removed will either receive active surveillance alone or six cycles of capecitabine and temozolo…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMORS (PNET)
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 17, 2026 15:16 UTC
-
New ultrasound techniques could sharpen pancreatic cancer diagnosis
Diagnosis Not yet recruitingThis study tests two new ultrasound imaging methods to improve how doctors tell different types of pancreatic tumors apart. Researchers will enroll 150 adults with solid pancreatic lesions to see if these techniques can more accurately diagnose pancreatic cancer and other tumors.…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMORS (PNET)
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated May 17, 2026 15:15 UTC